MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) – Trademark Portfolio
Entity Type: 03
MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include DIAION and NOVATEC. The owner is based in CHIYODA-KU, TOKYO 100.
5-2, MARUNOUCHI 2-CHOME
CHIYODA-KU, TOKYO 100 , JP
Showing of trademarks Trademarks
Trademark Classifications
MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION)'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) have?
MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) file in?
MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION)'s most well-known trademarks?
MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION)'s registered trademark portfolio includes well-known marks such as DIAION and NOVATEC. These are among 2 currently registered trademarks in the portfolio.
What is MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION)'s trademark registration success rate?
MITSUBISHI KASEI KABUSHIKI KAISHA (MITSUBISHI KASEI CORPORATION) has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.